Edgestream Partners’s Akero Therapeutics AKRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-6,947
Closed -$281K 835
2025
Q1
$281K Buy
+6,947
New +$281K 0.01% 772